Sentence examples for intermediate overall survival from inspiring English sources

This subgroup shows an intermediate overall survival between the wild-type and mutant groups, with nearly significant and equivalent differences between the different categories (data not shown).

ER-positive LN negative cancers have the best outcome, and ER-positive LN positive cases showed an intermediate overall survival, while TN and HER2 positive nonluminal types showed the shortest survival, as already reported [ 2, 3, 11, 14, 33].

Patients with either positive PET/CT and negative CA-125 or negative PET/CT and positive CA-125 had intermediate likelihood of overall survival.

A decline in prostate-specific antigen (PSA) is widely used to monitor treatment response, but is not validated as an intermediate endpoint for overall survival (OS).

The debate surrounding the acceptance of progression-free survival (PFS) as an intermediate endpoint to overall survival (OS) has grown in recent years, due to the challenges in demonstrating an OS benefit within clinical trials today.

The aforementioned phase III study is therefore incorporating the prospective evaluation of whether changes in CTC counts post treatment can serve as a robust intermediate endpoint for overall survival to accelerate drug development for CRPC.

Patients heterozygous for the SNP had an intermediate hazard ratio for overall survival (0.8; 95% confidence interval 0.5 1.3) (Sweeney et al, 2000).

In the intermediate-risk group, median overall survival was 20.7 months with the treatment of sunitinib compared to 15.4 months with interferon-α while the poor-risk group had a median survival of 5.3 months with sunitinib compared to 4.0 months with interferon-α.

Clinical response is frequently used as a surrogate intermediate endpoint for predicting disease-free survival and outcome after primary chemotherapy; pCR is a valid intermediate surrogate endpoint for predicting overall survival.

ERMS patients showing no or low to intermediate CD133 expression showed an overall survival around 75% which is comparable with the survival rate of translocation negative RMS patients [39].

Low- and intermediate-risk patients have an overall survival exceeding 90%, while newly diagnosed high-risk neuroblastoma and patients whose disease recurs show survival rates of 50% and less than 10%, respectively [75].